Congenica selected for final phase of Instand-NGS4P
May 21, 2024
Cambridge, United Kingdom – Congenica, a UK-based digital health company specialising in innovative software and solutions for genomic data analysis and interpretation, is pleased to announce its selection for the third phase of a contract to develop standardised Next-Generation Sequencing (NGS) workflows in oncology. The European Union Horizon 2020 co-funded project, ‘INtegrated and STANDardized NGS workflows [...]
May 21, 2024
The laboratory gives researchers a training ground for state-of-the-art DNBSEQ technology to further precision diagnostics and treatments Framingham, Mass. – Complete Genomics, a pioneering genomic sequencing company, today announced the May 22 opening of its Customer Experience Center (CEC) demonstration lab near Boston’s biotech hub. The new lab, located in Framingham near Boston, is Complete [...]
May 21, 2024
Boston – Dotmatics, a leader in R&D scientific software connecting science, data, and decision-making, today announced the release of Geneious Cloud Workspace and Geneious Prime 2024 to give researchers more efficiency in addressing the complexities in genomic data analysis and research. Geneious Cloud is designed to significantly improve the collaboration, data management, integration, and data portability capabilities for Geneious Prime customers [...]
Refeyn strengthens capability with new US Headquarters in Boston area
May 21, 2024
New US customer interaction center opens in Massachusetts’ Waltham Biotech Hub with 3rd annual Mass Photometry Summit set to highlight latest advances Refeyn’s new US headquarters to open in Massachusetts in Waltham’s Biotech Hub. Oxford, UK – Refeyn, the pioneer of mass photometry technology, is continuing to strengthen the deployment of its unique bioanalytical tools [...]
May 20, 2024
SHANGHAI, China — Duoning Biotechnology Group (“Duoning”), a leading one-stop bioprocess provider in China, today announced a strategic partnership with Bioelectronica, a company focusing on developing tools for single-cell/single-bacteria research. This partnership aims to enhance the global commercialization of the high-throughput single-cell sorting system Hypercell® and other related products. With joint efforts, the two companies [...]
SOPHiA GENETICS Announces Instituto Mario Penna as New Customer
May 20, 2024
The Hospital will enhance its testing and research of blood cancers with the SOPHiA DDM™ Platform Boston, MA and Rolle, Switzerland – SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced that Instituto Mário Penna is live on the SOPHiA DDM™ Platform. Located in Belo Horizonte, Brazil, [...]
Anna Richo joins Illumina’s Board of Directors
May 20, 2024
Ms. Richo brings more than 30 years of global legal, compliance, and regulatory experience to Illumina's Board SAN DIEGO -- Illumina, Inc. (NASDAQ: ILMN) announced today that Anna Richo has joined the company's Board of Directors following shareholder approval of the director slate at the company's May 16, 2024, annual meeting. Ms. Richo currently serves as [...]
May 20, 2024
Tokyo – Hitachi High-Tech Corporation (“Hitachi High-Tech”) and Hitachi, Ltd. ("Hitachi") announced a collaborative creation ("co-creation") that utilizes the Materials Informatics ("MI") solutions provided by the Hitachi Group on the “MACSiMUM*”, AI and machine learning platform, operated by Industrial Technology Research Institute ("ITRI"), the largest industrial technology research and development organization in Taiwan. With supported [...]
May 20, 2024
New Enhanced Small Particle (ESP™) Detection Option for Cytek Northern Lights™ and Cytek Aurora™ Systems Expands Capabilities of Small Particle Research FREMONT, Calif. -- Today Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, officially announced its Enhanced Small Particle (ESP™) Detection Option for its flagship Cytek Aurora™ and Cytek Northern Lights™ cell analysis systems. With [...]
May 20, 2024
The Fluidity One-M instrument with the inbuilt Microfluidic Diffusional Sizing (MDS) technology. Hertfordshire, UK – Fluidic Sciences Ltd., today announces its official launch as a company, and the commercial relaunch of the acquired Fluidity One-M instrument for measuring protein-protein interactions in solution—leveraging Microfluidic Diffusional Sizing (MDS) technology. The entry of Fluidic Sciences into the market gives scientists a [...]

